Overview

This bill amends the Mesothelioma Act 2014 to add a research supplement to the existing levy on insurers. This supplement will fund research into mesothelioma, a cancer caused by asbestos exposure.

Description

The Mesothelioma (Amendment) (No. 2) Bill modifies the 2014 Act by introducing a research supplement to the levy paid by insurers. This supplement:

• Will be a percentage (up to 1%) of the existing levy amount.
• Will be specifically allocated to fund research into mesothelioma through grants or other financial assistance.
• Will be managed by the scheme administrator, potentially with the help of a research funding body.
• May allow for funds collected in one period to be invested and allocated later.

Before implementing this supplement, the Secretary of State must consult insurers, medical charities, research foundations and other interested parties.

Government Spending

The bill will not directly increase or decrease government spending. Instead, it diverts a small percentage (up to 1%) of existing insurance levy funds towards mesothelioma research. The exact financial impact depends on the size of the levy and the percentage allocated to research. No figures are provided in the bill itself.

Groups Affected

• Insurers: Will pay a slightly increased levy.
• Mesothelioma sufferers and their families: May indirectly benefit from improved treatments and prevention strategies resulting from the funded research.
• Medical charities and research foundations: May receive funding for mesothelioma research.
• Researchers: May receive funding for their work on mesothelioma.

Powered by nyModel